CONSTANCE MORFAW: Open Payments
NPI 1942562848 · POTOMAC, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$581 in 28 payments from 11 companies in 2025. Trend: 2023 $472 · 2024 $1,002 · 2025 $581
Food & beverage: $581
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $187 |
| ABBVIE INC. | 5 | $119 |
| PFIZER INC. | 5 | $106 |
| Boston Scientific Corporation | 1 | $34 |
| Lilly USA, LLC | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Seqirus USA Inc | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: Wegovy, UBRELVY, Ozempic, NURTEC ODT, WaveWriter Alpha Prime 16, ELIQUIS, QULIPTA, MOUNJARO.
Industry payments across MD — which companies pay providers there.
